Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

Senescent neutrophils promote tumor survival across cancer types

Senescent neutrophils promote tumor survival across cancer types

Oxybutynin shows promise in managing hot flashes for prostate cancer patients

Oxybutynin shows promise in managing hot flashes for prostate cancer patients

Time of radiotherapy can influence the effectiveness of cancer treatment

Time of radiotherapy can influence the effectiveness of cancer treatment

Novel laser focal therapy device shows promising results for prostate cancer treatment

Novel laser focal therapy device shows promising results for prostate cancer treatment

New trial tests strategies to protect heart health during prostate cancer therapy

New trial tests strategies to protect heart health during prostate cancer therapy

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

PSA-based tool improves decision making for prostate cancer screening and treatment

PSA-based tool improves decision making for prostate cancer screening and treatment

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Cancer mortality drops 34% as treatments and early detection improve

Cancer mortality drops 34% as treatments and early detection improve

Common food preservatives may raise cancer risk

Common food preservatives may raise cancer risk

AI trained on sleep data predicts future disease and mortality years in advance

AI trained on sleep data predicts future disease and mortality years in advance

Advanced AI provides accurate guidance for prostate cancer patients

Advanced AI provides accurate guidance for prostate cancer patients

Dietary exposure to food preservatives associated with higher cancer incidence

Dietary exposure to food preservatives associated with higher cancer incidence

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

AI model can predict a person's disease risk using sleep data

AI model can predict a person's disease risk using sleep data

New trial aims to improve both survival and quality of life for men with advanced prostate cancer

New trial aims to improve both survival and quality of life for men with advanced prostate cancer

In the vast expanses of Indian country, broadband gaps create health gaps, too

In the vast expanses of Indian country, broadband gaps create health gaps, too

Early scans reveal prostate radiotherapy toxicity risk

Early scans reveal prostate radiotherapy toxicity risk

Triaptosis could be a promising strategy in the fight against cancer

Triaptosis could be a promising strategy in the fight against cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.